NANETS produces a monthly eNewsletter, Net News. Net News contains information on recent NET disease research, guidelines and resources. It also highlights NET continuing medical education (CME) programming, medical society developments, member accomplishments and news from other NET organizations. Have news to share? Contact us! Net News is a benefit of membership in NANETS. Not a member? Subscribe now!


Surgical PNETs Guidelines Published

Pancreas Journal of Neuroendocrine Tumors and Pancreatic Diseases and Sciences has published the North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors in its January 2020 issue.         

In Spring 2018, members of the NET surgical medical community convened a multidisciplinary panel to review a series of questions pertinent to surgeons caring for patients with pancreatic neuroendocrine tumors. These guidelines are the result of careful review of the available literature and comprehensive recommendations by the panel over a period of 18 months. 

2019 Member Interest Survey Results

                                                           

The goal of NANETS’ membership survey was to collect input on new programs and initiatives in three key areas: web-based learning, committee and volunteer interests, and a mentee/mentor program. The survey was distributed to all members and non-member Symposium attendees, with 61 respondents completing the entire survey. 

Web-Based Learning: 
Asked about web-based learning, 62 percent of respondents said they would be likely to attend a 60-minute webinar. When asked to list their top three topic preferences, PRRT was mentioned the most (18 mentions), followed by treatment and management of NETs (16 mentions) and clinical trials/latest research (10 mentions). Specific recommendations in these topic areas included:

  • PRRT: Sequencing and dosimetry; tailored PRRT; patient follow up; novel developments; emerging radionuclides and therapeutics
  • Treatment and Management of NETs: Standards of care; treatment options; sequencing; G3 NETS; new developments/emerging treatments
  • Clinical Trials/Latest Research: New targeted therapies; clinical trial opportunities in NETs; current, ongoing and recently completed clinical trials; updates on current research with application to clinic

Committee and Volunteer Interests: 
To broaden and diversify engagement of members on committees and task forces, a two-part question was posed. The first question asked respondents to check all areas in which they are interested in becoming involved or learning more about. Out of the 13 areas of interest, Scientific Review & Research received the most interest (70% of respondents); NET Symposium Planning was next with 56% of respondents indicating interest; and Consensus Guidelines received interest from 48% of respondents. The chart below displays these results, which are consistent with the society’s mission to further NET education and research.
               

NANETS Refines Its Committee Structure

In November, NANETS' board approved the reconfiguration of committees to better fulfill the society’s mission and to implement the goals of its 2020 strategic plan. The executive committee has advanced a new committee structure, which involves more members from difference specialties and areas of North America, better engages our allied health members, and puts forth a plan for succession.